(Q57064777)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

title

HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

author name string

C Loveday

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

S Kaye

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

M Tenant-Flowers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

U Ayliffe

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

I V Weller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

R S Tedder

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

language of work or name

English

0 references

publication date

1 April 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

volume

345

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

issue

8953

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

page(s)

820-824

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro

20 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Quantitation of human immunodeficiency virus type 1 in the blood of infected persons

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Plasma viremia in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Zidovudine for mother, fetus, and child: hope or poison?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

HIV-1 plasma viraemia quantification: A non-culture measurement needed for therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

A microtitre format point mutation assay: application to the detection of drug resistance in human immunodeficiency virus type-1 infected patients treated with zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Enzyme-linked immunosorbent assays for the measurement of human immunodeficiency virus, type 1 reverse transcriptase antigen and antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

High-Level Viremia in Adults and Children Infected with Human Immunodeficiency Virus: Relation to Disease Stage and CD4+ Lymphocyte Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

A pilot study of low-dose zidovudine in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2895%2992963-0

7 January 2021

10.1016/S0140-6736(95)92963-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7534858%20AND%20SRC:MED&resulttype=core&format=json

20 October 2019

1 reference